Practical application of new technologies for melanoma diagnosis : Part I. Noninvasive approaches - 16/05/15
Abstract |
Confirming a diagnosis of cutaneous melanoma requires obtaining a skin biopsy specimen. However, obtaining numerous biopsy specimens—which often happens in patients with increased melanoma risk—is associated with significant cost and morbidity. While some melanomas are easily recognized by the naked eye, many can be difficult to distinguish from nevi, and therefore there is a need and opportunity to develop new technologies that can facilitate clinical examination and melanoma diagnosis. In part I of this 2-part continuing medical education article, we will review the practical applications of emerging technologies for noninvasive melanoma diagnosis, including mobile (smartphone) applications, multispectral imaging (ie, MoleMate and MelaFind), and electrical impedance spectroscopy (Nevisense).
Le texte complet de cet article est disponible en PDF.Key words : MelaFind, melanoma, mobile app, MoleMate, Nevisense, spectroscopy, teledermatology
Abbreviations used : EIS, FDA, MSI, SIA, SK
Plan
Dr Grossman is supported by the University of Utah Department of Dermatology and the Huntsman Cancer Foundation. Mr March is supported by an award from the University of Nevada School of Medicine Office of Medical Research. |
|
Conflicts of interest: None declared. |
|
Date of release: June 2015 |
|
Expiration date: June 2018 |
Vol 72 - N° 6
P. 929-941 - juin 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?